Life sciences organizations have invested heavily in data and analytics, yet timely decision making remains a challenge. | Within3 leaders discuss why ownership, insight sharing and human judgment are critical to faster decisions.
Biological endpoints are essential, but on their own, they cannot tell the full story. To truly understand the value of a treatment and care surrounding it, we must also seek to understand how patients and carers experience it. This is where patient-reported outcomes (PROs) and observer‑reported outcomes (reflecting the perspectives of non-clinical caregivers) are becoming more prominent in clinical research.